Valuation for National Health Investors (id:9418 NHI)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 24,00 |
|
|
| Forward P/E | 22,25 |
|
|
| Price to sales | 9,62 |
|
|
| Price to book | 2,07 |
|
|
| Enterprise to revenue | 13,99 |
|
|
| Enterprise to ebitda | 18,01 |
|
|
| PEG ratio | 22,25 |
|
|
| Price to operating cash flow | 15,60 |
|
|